首页> 外文期刊>Reproductive Biology and Endocrinology >Whether G-CSF administration has beneficial effect on the outcome after assisted reproductive technology? A systematic review and meta-analysis
【24h】

Whether G-CSF administration has beneficial effect on the outcome after assisted reproductive technology? A systematic review and meta-analysis

机译:G-CSF给药对辅助生殖技术后的结局是否有有益效果?系统评价和荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

Background Previous studies have explored the effect of granulocyte colony stimulating factor (G-CSF) administration on the outcome of assisted reproductive technology (ART), and came into controversial conclusions. The present meta-analysis aims to assess whether G-CSF administration has beneficial effect on the outcome after ART. Method The electronic databases Pubmed, Embase and Google Scholar were searched up to May 2016. Articles that studied the effect of G-CSF administration on the outcome after ART were included in the present meta-analysis. Odds ratio (OR) with 95?% confidence interval (95 % CI) were calculated to assess the effect of G-CSF administration on the outcome after ART. The outcomes of interest were implantation rate (IR) and pregnancy rate (PR). Results Four cohort studies with 1101 embryos transplantation assessed the effect of G-CSF administration on IR and 6 studies with 621?cycles assessed the role of G-CSF administration in PR. Meta-analysis did not found an increased embryo IR in G-CSF administration cycles [OR 1.59 (95?% CI 0.74–3.41). whereas the PR with G-CSF administration was significantly higher compared with cases without G-CSF administration [OR 2.03 (95?% CI 1.19–3.46)]. Additionally, we found that G-CSF administrated subcutaneously resulted in significantly higher PR [OR 3.12 (95?% CI 1.67–5.81)] and IR [OR 2.82 (95?% CI 1.29–6.15)] compared with control group, whereas G-CSF administrated via local uterine infusion had no beneficial effect on the PR [OR 1.42 (95?% CI 0.91–2.24)] and IR [OR 1.10 (95?% CI 0.76–1.60)] after ART. Conclusions G-CSF administration may have beneficial effect on clinical pregnancy outcome after ART. Subcutaneous injection may be an optimal route of G-CSF administration. Further cohort studies are required to explore the mechanisms undergone the effect and investigate the best route and dose of G-CSF administration.
机译:背景先前的研究探索了粒细胞集落刺激因子(G-CSF)施用对辅助生殖技术(ART)结局的影响,并得出了有争议的结论。本荟萃分析旨在评估G-CSF给药是否对ART后的结局具有有益作用。方法检索截至2016年5月的电子数据库Pubmed,Embase和Google Scholar。目前的荟萃分析包括研究G-CSF给药对ART术后结局的影响的文章。计算出具有95%置信区间(95%CI)的赔率(OR),以评估G-CSF给药对ART治疗后结局的影响。感兴趣的结果是植入率(IR)和妊娠率(PR)。结果4项队列研究和1101枚胚胎移植评估了G-CSF施用对IR的影响,6项研究用621?周期评估了G-CSF施用在PR中的作用。荟萃分析未发现在G-CSF给药周期中胚胎IR升高[OR 1.59(95%CI 0.74–3.41)。与不使用G-CSF的患者相比,使用G-CSF的患者的PR显着更高[OR 2.03(95%CI 1.19–3.46)。此外,我们发现皮下注射G-CSF与对照组相比,PR [OR 3.12(95%CI 1.67–5.81)]和IR [OR 2.82(95%CI 1.29–6.15)]显着更高,而G通过局部子宫输注给予的-CSF对ART后的PR [OR 1.42(95%CI 0.91–2.24)]和IR [OR 1.10(95%CI 0.76–1.60)]无有益作用。结论G-CSF给药可能对ART术后临床妊娠结局具有有益作用。皮下注射可能是G-CSF给药的最佳途径。需要进行进一步的队列研究,以探索发生这种作用的机制,并研究G-CSF给药的最佳途径和剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号